ストックスクリーナーアプリを入手
23.02
2.17%
-0.51
アフターアワーズ：
23.02
前日終値:
$23.53
開ける：
$23.7
24時間の取引高:
6.61M
Relative Volume:
1.03
時価総額：
$11.90B
収益：
$11.32B
当期純損益:
$-981.00M
株価収益率:
-11.79
EPS:
-1.9532
ネットキャッシュフロー:
$714.00M
1週間 パフォーマンス:
-4.80%
1か月 パフォーマンス:
-11.15%
6か月 パフォーマンス:
+30.65%
1年 パフォーマンス:
-0.78%
1日の値動き範囲:
$22.98
$23.73
1週間の範囲:
$22.98
$24.77
52週間の値動き範囲:
$15.73
$30.00
Baxter International Inc Stock (BAX) Company Profile
名前
Baxter International Inc
セクター
電話
(224) 948-2000
住所
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, RMD, ALC, MDLN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
23.02 | 12.30B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
383.54 | 130.41B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
181.38 | 48.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
228.42 | 31.49B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
65.18 | 31.92B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
32.12 | 28.54B | 29.14B | 1.07B | 1.05B | 1.1956 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-31 | ダウングレード | Argus | Buy → Hold |
| 2025-08-04 | ダウングレード | Stifel | Buy → Hold |
| 2025-08-01 | ダウングレード | Goldman | Buy → Neutral |
| 2025-02-26 | 再開されました | Goldman | Buy |
| 2025-02-24 | アップグレード | Argus | Hold → Buy |
| 2025-02-20 | 再開されました | Barclays | Overweight |
| 2024-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 開始されました | Goldman | Neutral |
| 2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-12-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-12-15 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-12-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-06-24 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | ダウングレード | Goldman | Neutral → Sell |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-18 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-18 | 繰り返されました | Raymond James | Outperform |
| 2022-02-18 | 繰り返されました | Stifel | Buy |
| 2022-02-18 | 繰り返されました | UBS | Neutral |
| 2022-02-18 | 繰り返されました | Wells Fargo | Overweight |
| 2022-02-11 | 開始されました | Goldman | Neutral |
| 2022-01-07 | 再開されました | Citigroup | Buy |
| 2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-09-03 | アップグレード | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | ダウングレード | UBS | Buy → Neutral |
| 2020-12-15 | ダウングレード | Goldman | Buy → Neutral |
| 2020-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2020-09-04 | ダウングレード | Argus | Buy → Hold |
| 2020-06-24 | 開始されました | Oppenheimer | Outperform |
| 2020-03-19 | アップグレード | Stifel | Hold → Buy |
| 2020-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-13 | 開始されました | Goldman | Buy |
| 2020-01-02 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-17 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-01-02 | アップグレード | Citigroup | Neutral → Buy |
| 2019-01-02 | アップグレード | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | アップグレード | Argus | Hold → Buy |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-05-17 | 再開されました | Piper Jaffray | Overweight |
| 2018-02-06 | 繰り返されました | Citigroup | Neutral |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2018-01-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
すべてを表示
Baxter International Inc (BAX) 最新ニュース
Baxter International Inc Share PriceBAX, RNS News, Articles, Quotes, & Charts (NYSE:BAX) - Proactive financial news
Securities Lawsuit Alert: Baxter International, Inc. (BAX) – Contact Levi & Korsinsky Before December 15, 2025 - ACCESS Newswire
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter International stock heads into the open after a modest gain - ad-hoc-news.de
Intravenous Immunoglobulin Market Size Worth USD 30.83 Billion by 2035, Growing at 7.49% CAGR – SNS Insider - GlobeNewswire Inc.
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Transcript : Baxter International Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 12 - marketscreener.com
Baxter at Wells Fargo conference: growth improves as turnaround continues By Investing.com - Investing.com UK
A Look at Baxter International Inc (BAX) After 3.8% Decline -- G - GuruFocus
Baxter International stock trades sideways as technical signals flag limited near-term upside - ad-hoc-news.de
Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Baxter International stock holds steady as investors await next earnings signal - ad-hoc-news.de
BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure - Yahoo Finance
Human Albumin Market Report Analyzes Growth Factors, Challenges, and Market Dynamics - openPR.com
Don't Ignore The Insider Selling In Abeona Therapeutics - simplywall.st
Baxter International Inc. (BAX) Stock Analysis: Exploring Potential Upside and Analyst Ratings - DirectorsTalk Interviews
Nagaraj Bhat Appointed Vice President/GM, Global Capability Center (GCC) Site Leader at DePuy Synthes - hrtoday.in
Baxter International stock holds steady as investors focus on recent restructuring and earnings prof - ad-hoc-news.de
ETFs Investing in Baxter International Inc. Stocks - TradingView
Before Mark Walter’s companies faced inquiries, he kept a low profile and built loyalty - Los Angeles Times
Two IV Saline Recalls Within Days Cite Iron Oxide and Fiberglass Particles Found Inside Sealed Hospital Bags - Medical Daily
IV bags recalled in MD over potential fiberglass contamination - Maryland Daily Record
Baxter International Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Baxter International stock holds steady as investors digest latest quarterly figures - ad-hoc-news.de
Jerry Flansburg Obituary (2026)International Falls, MNRainy Lake Gazette - Legacy obituary
Baxter International CEO Andrew P. Hider Surrenders Shares for Tax Withholding on September 2, 2026 - Kalkine Media
Baxter (NYSE: BAX) exec ends with 29,164 shares after tax move - Stock Titan
Recalls issued for possible fiberglass particles in IV solutions made at WNC facility: FDA - WLOS
Baxter International stock gains after strong Q2 figures - ad-hoc-news.de
Baxter International's Julie Foster Reports RSU-Related Share Forfeiture - Kalkine Media
Taiwan's Best Companies to Work for in Asia Transformed a Talent Crisis into a Strategic Advantage - PR Newswire
Baxter International stock holds gains as recalls and earnings shape sentiment - AD HOC NEWS
Baxter International stock could double, Tom Hayes says - finance.yahoo.com
FDA recalls saline bags in 14 states over possible fiberglass contamination - thecooldown.com
List of 21 Acquisitions by Baxter (Sep 2026) - Tracxn
Baxter International stock steadies as recall news meets mixed analyst view - AD HOC NEWS
Baxter International Inc. (BAX) Stock Analysis: Exploring a 9.94% Potential Upside Amidst Healthcare Sector Dynamics - DirectorsTalk Interviews
Baxter: This Turnaround Stock Is Up and Still 38% Undervalued - Morningstar
2 drugs recalled over potential fiberglass, steel presence - WGN-TV
Saline bags recalled in 14 states due to potential fiberglass contamination - kare11.com
Fiberglass in IV saline? Texas among states included in recall - MySA
Baxter International Inc. (BAX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Saline used in IV injections recalled nationwide due to fiberglass - FOX 8 News
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Several Baxter vaccine, solution lots recalled due to potential ‘particulate matter’ - WFMJ
Licensable picture: Baxter International CEO and President Robert Parkinson Jr. looks over at the families of the victims of Heparin reactions testifying during a House Energy and Commerce subcommittee hearing on Heparin imports from China on Capitol Hill - reutersconnect.com
Baxter International Inc To Go Ex-Dividend On August 28th, 2026 With 0.01 USD Dividend Per Share - 富途牛牛
Baxter Issues Voluntary Nationwide Recall for One Lot of Anticoagulant Sodium Citrate Solution Due to Potential Presence of Particulate Matter - USA Today
Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with Potential 9.06% Upside - DirectorsTalk Interviews
Baxter International stock holds steady as new CFO joins and analyst estimates shift - Ad-hoc-news.de
Zacks Research Issues Negative Estimate for BAX Earnings - MarketBeat
Baxter International Inc (BAX) 財務データ
収益
当期純利益
現金流量
EPS
1.60%
0.49%
大文字化:
|
ボリューム (24 時間):